The Board of Directors of Dignitana AB has appointed Magnus Blixt as the new CEO of Dignitana.
He will assume CEO responsibilities after the Annual General Meeting on 25 May 2022. At that time current CEO William Cronin will transition to serve as Deputy Chairman of the Board of Directors and will be a Senior Advisor to the company regarding US market and reimbursement strategies.
“The strategic expansion of the company is our top priority,” says Klas Arildsson, Chairman of the Board, Dignitana. “We are well-positioned to take advantage of the opportunities before us in the critical US market and around the globe, and the financial and operational experience that Magnus Blixt brings will be a tremendous asset to the company.”
Magnus Blixt is currently CFO of CellaVision AB. Blixt has held that role since 2013 and has supported a growth agenda generated by a scalable indirect business model. He has extensive experience developing small and medium-sized companies focusing on business performance and process improvements. He previously held positions in the SKF Group as Business Demand Manager and Operations Manager, and as CFO of an SKF Sealing Solutions company in the United States he supported the integration of that company into the broader SKF organization. He has an MBA from Lund University.
“I appreciate the entrepreneurial spirit of Dignitana and I see many similarities in this company compared to where CellaVision was when I joined that company,” says Magnus Blixt. “Dignitana is a growing company with tremendous potential – it has global reach, an excellent product, and a solid foundation. I am excited about the opportunity and look forward to continuing the good work of the company to improve well-being and the lives of cancer patients.”
To support Dignitana’s commitment to global expansion the CEO position will be based at the company headquarters in Lund along with other key positions.